Radiotherapy-resistant endometrial cancer subtype identified

Article

Canadian researchers have identified a type of endometrial cancer—a uterine papillary serous carcinoma (UPSC)—that is resistant to radiotherapy.

Canadian researchers have identified a type of endometrial cancer-a uterine papillary serous carcinoma (UPSC)-that is resistant to radiotherapy.

They analyzed the medical records of 62 women with biopsy-proven endometrial cancer of at least stage II who were treated with radiotherapy followed by hysterectomy. They looked at variables such as patient characteristics, tumor stage, histologic grade and subtype, and radiation technique and dose to determine if any were associated with the complete pathologic response to treatment that occurred in 24 of the women.

It turned out that the only variable predictive of response to treatment was whether the cancer was a UPSC; none of the seven women with a UPSC responded well to radiotherapy, even though they were comparable to the other women in all other regards.

Related Videos
Understanding combined oral contraceptives and breast cancer risk | Image Credit: health.ucdavis.edu
Why doxycycline PEP lacks clinical data for STI prevention in women
The importance of nipocalimab’s FTD against FNAIT | Image Credit:  linkedin.com
Enhancing cervical cancer management with dual stain | Image Credit: linkedin.com
Fertility treatment challenges for Muslim women during fasting holidays | Image Credit: rmanetwork.com
Understanding the impact of STIs on young adults | Image Credit: providers.ucsd.edu.
CDC estimates of maternal mortality found overestimated | Image Credit: rwjms.rutgers.edu.
Study unveils maternal mortality tracking trends | Image Credit: obhg.com
How Harmonia Healthcare is revolutionizing hyperemesis gravidarum care | Image Credit: hyperemesis.org
Unveiling gender disparities in medicine | Image Credit:  findcare.ahn.org.
© 2024 MJH Life Sciences

All rights reserved.